Table 1 Clinical characteristics of the overall population at baseline and follow-up

Patients (n)

16

13

Age (years)

45 ± 13

50 ± 14

Male gender, n (%)

8 (50)

6 (62)

Weight (kg)

68 ± 12

70 ± 11

Hypertension, n (%)

5 (31)

5 (38)

Smoking, n (%)

1 (6)

1 (8)

Classic Anderson–Fabry disease, n (%)

13 (81)

10 (77)

Late onset Anderson–Fabry disease, n (%)

3 (19)

3 (23)

Enzyme replacement therapy, n (%)

6 (37)

12 (92)

Left ventricular mass (g)

58 ± 23

54 ± 8

Left ventricular end-diastolic volume (mL)

77 ± 19

76 ± 7

Left ventricular end-systolic volume (mL)

26 ± 10

29 ± 2

Left ventricular ejection fraction (%)

67 ± 7

63 ± 7